摘要
目的探讨小剂量甲状腺素联合厄贝沙坦氢氯噻嗪治疗老年重症心力衰竭的临床疗效。方法选取2014年1月-2015年12月间我院收治的老年重症心力衰竭患者80例,随机分为对照组和观察组,每组各40例。对照组患者接受常规药物治疗,观察组患者接受小剂量甲状腺素联合厄贝沙坦氢氯噻嗪药物治疗。治疗结束后,观察并比较两组患者的临床疗效。结果观察组的总有效率为92.5%,明显优于对照组的75.0%,差异有统计学意义(P<0.05)。结论采用小剂量甲状腺素联合厄贝沙坦氢氯噻嗪对老年重症心力衰竭患者进行治疗,能够明显提高临床疗效,安全可靠且有效,值得在临床上推广以及应用。
Objective To investigate the clinical efficacy of small dose thyroxine combination with irbesartan and hydrochlorothiazide in the treatment of senile severe heart failure. Methods From January 2014 to December 2015, 80 senile severe heart failure patients were enrolled as the research object and were randomly divided into two groups： the observation group and the control group, 40 cases in each group. The patients in the control group accepted routine drug treatment and those in the observation group accepted small dose thyrox- ine combination with irbesartan and hydrochlorothiazide treatment. After the treatment, the clinical efficacy of the two groups was observed. Results The total effective rate of the observation group was 92.5%, significantly higher than that of the control group （75.0%）, with significant difference （P〈0.05）. Conclusion In the treatment of senile severe heart failure patients, small dose thyroxine combination with irbesartan and hydrochlorothiazide can significantly improve the clinical curative efficacy, and it is safe, reliable and effective. So it is worth popularizing in clinical application.
出处
《临床检验杂志（电子版）》
2016年第2期96-98,共3页
Clinical Laboratory Journal(Electronic Edition)
关键词
甲状腺素
厄贝沙坦氢氯噻嗪
重症心力衰竭
Thyroxine
lrbesartan and hydrochlorothiazide
Severe heart failure
